NO20074978L - Fremgangsmate for fremstilling av optisk aktive denvater av 2-(2-pyndylmetylsulfinyl)-benzimidazol via inklusjonskompleks med 1,1'-binaftalen-2,2'diol - Google Patents

Fremgangsmate for fremstilling av optisk aktive denvater av 2-(2-pyndylmetylsulfinyl)-benzimidazol via inklusjonskompleks med 1,1'-binaftalen-2,2'diol

Info

Publication number
NO20074978L
NO20074978L NO20074978A NO20074978A NO20074978L NO 20074978 L NO20074978 L NO 20074978L NO 20074978 A NO20074978 A NO 20074978A NO 20074978 A NO20074978 A NO 20074978A NO 20074978 L NO20074978 L NO 20074978L
Authority
NO
Norway
Prior art keywords
benzimidazole
inclusion complex
binaphthalene
diol
preparation
Prior art date
Application number
NO20074978A
Other languages
English (en)
Norwegian (no)
Inventor
Laura Coppi
Ramon Berenguer Maimo
Yolanda Gasanz Guillen
Jorge Medrano Ruperez
Original Assignee
Esteve Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica Sa filed Critical Esteve Quimica Sa
Publication of NO20074978L publication Critical patent/NO20074978L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
NO20074978A 2005-03-03 2007-10-02 Fremgangsmate for fremstilling av optisk aktive denvater av 2-(2-pyndylmetylsulfinyl)-benzimidazol via inklusjonskompleks med 1,1'-binaftalen-2,2'diol NO20074978L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200500546A ES2259269B1 (es) 2005-03-03 2005-03-03 Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
PCT/EP2006/060193 WO2006094904A1 (en) 2005-03-03 2006-02-22 Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol

Publications (1)

Publication Number Publication Date
NO20074978L true NO20074978L (no) 2007-11-23

Family

ID=36293310

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074978A NO20074978L (no) 2005-03-03 2007-10-02 Fremgangsmate for fremstilling av optisk aktive denvater av 2-(2-pyndylmetylsulfinyl)-benzimidazol via inklusjonskompleks med 1,1'-binaftalen-2,2'diol

Country Status (19)

Country Link
US (1) US7777044B2 (de)
EP (1) EP1858881B1 (de)
JP (1) JP5097559B2 (de)
KR (1) KR101246479B1 (de)
CN (1) CN101133049B (de)
AT (1) ATE406362T1 (de)
AU (1) AU2006222032B2 (de)
CA (1) CA2598224C (de)
CY (1) CY1108491T1 (de)
DE (1) DE602006002495D1 (de)
DK (1) DK1858881T3 (de)
ES (2) ES2259269B1 (de)
HR (1) HRP20080510T3 (de)
MX (1) MX2007010705A (de)
NO (1) NO20074978L (de)
NZ (1) NZ561214A (de)
PT (1) PT1858881E (de)
WO (1) WO2006094904A1 (de)
ZA (1) ZA200707335B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056804A2 (en) * 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd. Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
KR100641534B1 (ko) 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법
MY148301A (en) * 2006-07-05 2013-03-29 Lupin Ltd Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
ATE534643T1 (de) * 2007-06-07 2011-12-15 Aurobindo Pharma Ltd Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers
WO2009087672A1 (en) * 2007-12-18 2009-07-16 Watson Pharma Private Limited A process for preparation of stable amorphous r-lansoprazole
WO2010079504A2 (en) * 2008-05-14 2010-07-15 Watson Pharma Private Limited Stable r(+)-lansoprazole amine salt and a process for preparing the same
CN101391993B (zh) * 2008-10-28 2012-07-04 安徽美诺华药物化学有限公司 通过与(s)-(-)-1,1'-联萘-2,2'-二酚形成包合配合物制备s-奥美拉唑及其盐的方法
WO2010058409A2 (en) 2008-11-18 2010-05-27 Hetero Research Foundation Optical purification of esomeprazole
EP2376476B1 (de) * 2008-12-24 2014-06-25 KRKA, tovarna zdravil, d.d., Novo mesto Verfahren zur herstellung von esomeprazol
EP2499125B1 (de) 2009-11-12 2016-01-27 Hetero Research Foundation Verfahren zur racematspaltung von omeprazol
CN102887885B (zh) * 2012-09-26 2014-12-10 江苏正大丰海制药有限公司 一种埃索美拉唑钠的制备方法
CN103483407B (zh) * 2013-10-10 2015-11-18 宁夏启元药业有限公司 一种硫氰酸红霉素萃取结晶用复合溶媒及萃取结晶方法
EP2980086B1 (de) 2014-07-29 2016-06-15 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Effizientes Verfahren zur Herstellung von Esomeprazol (S)-Binol Komplex
CZ2014710A3 (cs) * 2014-10-17 2016-05-11 Vysoká škola chemicko - technologická v Praze Močovina na bázi binaftalenu pro stanovení enantiomerní čistoty chirálních sulfoxidů pomocí 1H-NMR analýzy
CZ307419B6 (cs) * 2014-10-17 2018-08-08 Vysoká škola chemicko-technologická v Praze Způsob stanovení enantiomerní čistoty chirálních sulfoxidů pomocí 1H-NMR analýzy
CN105294544B (zh) * 2015-11-30 2017-09-22 山东罗欣药业集团股份有限公司 一种高纯度匹可硫酸钠的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
CN1087739C (zh) * 1998-12-28 2002-07-17 中国科学院成都有机化学研究所 光学纯的苯并咪唑类抗消化性溃疡药物的包结拆分制备法
SE9900274D0 (sv) 1999-01-28 1999-01-28 Astra Ab New compound
TWI275587B (en) 1999-06-17 2007-03-11 Takeda Chemical Industries Ltd A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
CN1117747C (zh) * 2000-06-19 2003-08-13 中国科学院成都有机化学研究所 光学纯兰索拉唑的制备方法
WO2004002982A2 (en) 2002-06-27 2004-01-08 Dr. Reddy's Laboratories Limited A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof
TW200410955A (en) 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
CN1223262C (zh) * 2003-08-07 2005-10-19 广水市东晨菌业科技有限公司 天麻有性繁殖同步栽培的方法
KR100641534B1 (ko) 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법
AU2006331373B2 (en) 2005-12-28 2011-06-02 Union Quimico Farmaceutica, S.A. A process for the preparation of the (S)-enantiomer of omeprazole

Also Published As

Publication number Publication date
DE602006002495D1 (de) 2008-10-09
WO2006094904A1 (en) 2006-09-14
CN101133049B (zh) 2011-03-30
DK1858881T3 (da) 2008-12-01
HRP20080510T3 (hr) 2008-12-31
KR20070113212A (ko) 2007-11-28
CY1108491T1 (el) 2014-04-09
CA2598224A1 (en) 2006-09-14
US7777044B2 (en) 2010-08-17
JP5097559B2 (ja) 2012-12-12
ES2259269B1 (es) 2007-11-01
KR101246479B1 (ko) 2013-03-21
AU2006222032B2 (en) 2011-03-10
ES2259269A1 (es) 2006-09-16
EP1858881A1 (de) 2007-11-28
EP1858881B1 (de) 2008-08-27
JP2008531641A (ja) 2008-08-14
NZ561214A (en) 2009-09-25
ZA200707335B (en) 2008-12-31
ATE406362T1 (de) 2008-09-15
CA2598224C (en) 2012-08-28
PT1858881E (pt) 2008-10-08
MX2007010705A (es) 2007-11-08
US20080167473A1 (en) 2008-07-10
AU2006222032A1 (en) 2006-09-14
CN101133049A (zh) 2008-02-27
ES2313617T3 (es) 2009-03-01

Similar Documents

Publication Publication Date Title
NO20074978L (no) Fremgangsmate for fremstilling av optisk aktive denvater av 2-(2-pyndylmetylsulfinyl)-benzimidazol via inklusjonskompleks med 1,1'-binaftalen-2,2'diol
WO2009020323A3 (en) Process for preparing voriconazole
EP0836601B1 (de) Verfahren zur optischen reinigung von enantiomer angereicherten benzimidazolderivaten.
KR101898829B1 (ko) 마이크로솜 프로스타글란딘 e2 신타제-1을 억제하는데 유용한 신규한 메틸-피페리딘 화합물
EP1897877A3 (de) Verfahren zur Herstellung eines Kristalls
CY1121372T1 (el) Μεθοδος για την παρασκευη καθαρισμενων ανσαμιτοκινων
EP2679576A3 (de) Verfahren zur Herstellung von kristallinen Formen von optischen Enantiomeren von Modafinil und ihre pharmazeutischen Zusammensetzung.
WO2008062478A3 (en) Improved process for pure montelukast sodium through pure intermediates as well as novel amine salts
EA201001395A1 (ru) Специфичные примеси монтелукаста
HRP20050604B1 (hr) Postupak priprave optiäśki äśistih aktivnih spojeva
AU2003246829A1 (en) Solvent-based sterilisation of pharmaceuticals
DK1877384T3 (da) Fremgangsmåde til fremstilling af eventuelt 2-substituerede 1,6-dihydro-6-oxo-4-pyrimidincarboxylsyrer
WO2006003471A3 (en) Process for the preparation of pramipexole by chiral chromatography
DE60203944D1 (de) Verbesserte herstellung von ceftiofur zwischenprodkten
UA99455C2 (ru) Эпоксидное соединение, способ его получения и способ получения соединения оксазола
DK1889834T3 (da) Ny organisk forbindelse og fremgangsmåde til at fremstille radioaktiv halogenmærket organisk forbindelse ved anvendelse af samme
BRPI0512251A (pt) método enantioseletivo para separação de derivados do ácido 2-trifluormetil-2h-cromeno-3-carboxìlico substituìdo
WO2009066321A3 (en) Process for optically active sulfoxide compounds
AR065305A1 (es) Metodo de preparacion y separacion estereoselectivas de tri-o-acetil-5-desoxi-beta-d-ribofuranosa
WO2010058409A3 (en) Optical purification of esomeprazole
EA200801338A1 (ru) Энантиоселективное получение производных бензимидазола и их солей
MA34142B1 (fr) Procede pour la preparation du 2-(cyclohexylmethyl)-1-methylpyrrolidin-2-yl)ethyl)-1,2,3,4-tetrahydroisoquinoleine-7-sulfonamide
EP2309040A4 (de) Verfahren zur herstellung von aixga(1-x)n-einkristall, aixga(1-x)n-einkristall und optische linsen
DK1665922T3 (da) Höbjergningsmaskine
WO2005056539A3 (en) A process for the resolution of nefopam

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application